Akebia Therapeutics, Inc. (AKBA)
1.47
-0.04
(-2.65%)
USD |
NASDAQ |
Jan 06, 16:00
1.49
+0.02
(+1.36%)
After-Hours: 20:00
Akebia Therapeutics Price: 1.47 for Jan. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 25.44 |
| Plus Therapeutics, Inc. | 0.5611 |
| Ironwood Pharmaceuticals, Inc. | 4.29 |
| Pyxis Oncology, Inc. | 1.29 |
| Theravance Biopharma, Inc. | 18.26 |
Price Related Metrics
| PS Ratio | 1.642 |
| Price to Book Value | 9.379 |
| Price to Free Cash Flow | 11.49 |
| Earnings Yield | -5.18% |
| Market Cap | 390.09M |
| Operating PE Ratio | 20.83 |